Legal Representation
Attorney
Joseph W. Berenato, III
USPTO Deadlines
Application History
45 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 8, 2025 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Oct 8, 2025 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jul 24, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 24, 2024 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Jul 24, 2024 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Jul 24, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 11, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 9, 2024 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Jan 9, 2024 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Jan 9, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 27, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 25, 2023 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Jul 25, 2023 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Jul 25, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 27, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 25, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jan 25, 2023 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jan 25, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 17, 2022 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Aug 9, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 8, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jul 27, 2022 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Aug 8, 2022 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Aug 3, 2022 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Jul 27, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 1, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Dec 7, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 7, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 17, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 4, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 12, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 12, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 12, 2021 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Sep 14, 2021 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Sep 14, 2021 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Sep 14, 2021 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Aug 5, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 5, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 5, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 5, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 5, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 5, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 19, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 15, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 12, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Prescription and nonprescription medicinal and pharmaceutical preparations, namely, tablets and capsules for use in the treatment of diseases and ailments affecting the gastrointestinal tract, blood, cardiovascular system, skin, endocrine system, respiratory system, musculoskeletal system; full line of prescription and nonprescription medicinal and pharmaceutical preparations
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"RESEARCH LABORATORIES"